COVID-19 could trigger a brain health time-bomb in the future. If so, what can we do now?
Learn about the unique challenges of COVID-19 on PD patients and tips on how best to prepare.
Stay ahead of the curve on the latest breakthroughs and testing availability.
Join the fight to end all brain disease.
A leader in Prion Detection Science™, Amprion innovates biomarker testing for brain diseases. Our SYNTap® Biomarker Test helps doctors diagnose Lewy Body Dementia, Parkinson’s, and distinguish synucleinopathy in Alzheimer’s. We plan to launch more biomarker tests in the future.
AMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2022 Amprion Inc. All rights reserved.
Privacy Policy | HIPAA Policy | Cookie Policy | Terms of UseAMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2022 Amprion Inc. All rights reserved. | Privacy Policy
| HIPAA Policy | Cookie Policy | Terms of Use
